Meilleure Health International Industry Group Limited (MEILLEUREHEALTH) will seek shareholder approval on 21 Apr 2026 for two key proposals:

1) Connected acquisition • MEILLEUREHEALTH intends to buy 100% of Jiangsu Yide Investment for RMB124.77 million (about HK$137 million). • Vendors are U-Home Group (40% equity holder) and Ms Tan Wensheng (60%). U-Home Group is wholly owned by executive director and controlling shareholder Mr Zhou Xuzhou; the deal is therefore a discloseable and connected transaction. • Jiangsu Yide owns 17 commercial units, 3 residential units and 34 parking spaces in Nanjing with a combined GFA of 5,306.36 sq m. Independent valuation set the investment properties’ market value at RMB131.23 million and the company’s equity value at RMB59.50 million. • All outstanding bank loans of RMB108.00 million will be settled by the vendors before completion. • Completion is targeted by 31 Dec 2026, with payment due within 90 days of shareholder approval. If conditions are not met, vendors must refund the consideration plus 8% p.a. liquidated damages; Mr Zhou has provided a personal guarantee.

2) Adoption of 2026 Share Award Scheme • Valid for 10 years with an initial mandate to issue up to 408.84 million new shares (10% of issued shares) and a 1% sub-limit (40.88 million shares) for Service Providers. • Eligible participants include employees, directors, related-entity staff and specified external service providers. • Vesting period is at least 12 months, with limited exceptions for make-whole grants or special circumstances. • No purchase price is payable by participants on vesting; the Board may impose performance conditions at its discretion.

Special General Meeting • Date & venue: 21 Apr 2026, 11:00 a.m. at The Center, 99 Queen’s Road Central, Hong Kong. • Shareholders’ register will be closed from 16 Apr to 21 Apr 2026. • Controlling shareholder Mr Zhou, Executive Director Ms Zhou and their associates (holding 63.18% of shares) will abstain from voting on the acquisition resolution.

If approved, the transaction would expand MEILLEUREHEALTH’s property-related income base, while the new share award scheme aims to align incentives of employees, related-party staff and key service providers with long-term shareholder value.